OXiGENE is a biopharmaceutical company whose mission is finding and developing new and improved therapeutics that can deliver significant medical benefits to patients with cancer and sight-threatening eye diseases and conditions.

Thursday, August 12, 2010
OXiGENE Reports Second Quarter 2010 Financial Results

Friday, August 6, 2010
OXiGENE Announces Second Quarter 2010 Earnings Conference Call and Webcast